Chronic myeloid leukemia

Abstract

Current chronic myeloid leukemia therapy with imatinib require the monitoring of hematological, cytogenetic and molecular response. Changes in treatment are provided on individual basis.

Keywords

• chronic myeloid leukemia
• treatment